Previous 10 | Next 10 |
Deals and Financings China Biologic Products (CBPO), a blood products company, received a $4.6 billion takeover offer from a group of six investment firms (see story ). The proposal was priced at $120 per share, a 16% premium to the previous close. CBPO operates plasma-gathering facilities ...
CASI Pharmaceuticals (NASDAQ: CASI ) promotes Larry Zhang to President. More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
ROCKVILLE, Md. , Sept. 19, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products, announces the promotion of Larry Zhang to President. Wei-Wu He , Ph....
ROCKVILLE, Md. , Sept. 16, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products, announces that the Chinese National Medical Product Administration (NMPA), the Ch...
The following slide deck was published by CASI Pharmaceuticals, Inc. in conjunction with this Read more ...
ROCKVILLE, Md. , Sept. 5, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China , U.S., and throughout the world, announces it will host a key opi...
ROCKVILLE, Md. , Sept. 3, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China , U.S., and throughout the world, announces it will present at the 2019 H...
CASI Pharmaceuticals (NASDAQ: CASI ) announces the product launch of EVOMELA (melphalan for injection) in China. More news on: CASI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...
ROCKVILLE, Md. , Aug. 12, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China , U.S., and throughout the world, announces the product launch of EVOMELA...
CASI Pharmaceuticals (NASDAQ: CASI ): Q2 GAAP EPS of -$0.16 misses by $0.07 . More news on: CASI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
CASI Pharmaceuticals Inc. Company Name:
CASI Stock Symbol:
NASDAQ Market:
CASI Pharmaceuticals Inc. Website:
2024-07-17 13:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP PR Newswire BEIJING , July 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing in...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 30.9% to $0.6 on volume of 558,931,853 shares NVIDIA Corporation (NVDA) fell 1.9% to $123.99 on volume of 249,243,816 shares Assure Holdings Corp. (IONM) rose 82.8% to $0.424 on vol...